Clinical trials
Phase 3 trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,610 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 11 |
| 2002 | 16 |
| 2003 | 32 |
| 2004 | 32 |
| 2005 | 67 |
| 2006 | 65 |
| 2007 | 78 |
| 2008 | 103 |
| 2009 | 82 |
| 2010 | 97 |
| 2011 | 96 |
| 2012 | 103 |
| 2013 | 104 |
| 2014 | 125 |
| 2015 | 114 |
| 2016 | 87 |
| 2017 | 124 |
| 2018 | 145 |
| 2019 | 134 |
| 2020 | 138 |
| 2021 | 154 |
| 2022 | 132 |
| 2023 | 149 |
| 2024 | 147 |
| 2025 | 142 |
| 2026 | 115 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,448 |
| Active, not recruiting | 412 |
| Recruiting | 350 |
| Terminated | 268 |
| Unknown status | 97 |
| Enrolling by invitation | 15 |
| Not yet recruiting | 10 |
| Withdrawn | 7 |
| Suspended | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 202 |
| Novartis Pharmaceuticals | 162 |
| Hoffmann-La Roche | 145 |
| Eli Lilly and Company | 143 |
| Pfizer | 126 |
| Merck Sharp & Dohme LLC | 106 |
| GlaxoSmithKline | 87 |
| Sanofi | 86 |
| Bristol-Myers Squibb | 82 |
| Janssen Research & Development, LLC | 79 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 165 |
| Diabetes Mellitus, Type 2 | 127 |
| Breast Neoplasms | 121 |
| Neoplasms | 76 |
| Neoplasm Metastasis | 67 |
| Carcinoma, Hepatocellular | 48 |
| Prostatic Neoplasms | 48 |
| Arthritis, Rheumatoid | 42 |
| Obesity | 42 |
| Pulmonary Disease, Chronic Obstructive | 41 |
Trials
Showing 1 to 25 of 2,610. Each trial links to its page on Pharma Observatory.
2,510 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.